# Dose Escalation Study Of Palifermin in Pediatric Research Participants Undergoing Allogeneic Hematopoietic Stem Cell Transplantation

> **NCT00701688** · PHASE1 · COMPLETED · sponsor: **St. Jude Children's Research Hospital** · enrollment: 19 (actual)

## Conditions studied

- Oral Mucositis
- Hematopoietic Stem Cell Transplantation

## Interventions

- **DRUG:** Palifermin

## Key facts

- **NCT ID:** NCT00701688
- **Lead sponsor:** St. Jude Children's Research Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-09
- **Primary completion:** 2011-09
- **Final completion:** 2012-02
- **Target enrollment:** 19 (ACTUAL)
- **Last updated:** 2012-03-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00701688

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00701688, "Dose Escalation Study Of Palifermin in Pediatric Research Participants Undergoing Allogeneic Hematopoietic Stem Cell Transplantation". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00701688. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*